Long‐Term Survival of Two Versus Three Courses of Preoperative Cisplatin and Fluorouracil Plus Docetaxel for Locally Advanced Esophageal Cancer: A Multicenter Randomized Phase II Trial

Documenti analoghi

• Prognostic factors for patients with esophageal cancer who achieve pathological complete response in the primary tumor after upfront chemotherapy or chemoradiotherapy
  di: Masaaki Motoori, et al.
  Pubblicazione: (2025)
• Exercise and Nutrition Prehabilitation Program During Preoperative Chemotherapy Followed by Esophagectomy in Older Patients With Esophageal Cancer: A Randomized Clinical Trial
  di: Keijiro Sugimura, et al.
  Pubblicazione: (2025)
• Postoperative Prognostic Nutritional Index as a Useful Prognostic Factor in Patients With Gastric Cancer
  di: Masaaki Yamamoto, et al.
  Pubblicazione: (2025)
• Prognostic factors of conversion surgery for stage IV gastric cancer: A multi‐institutional retrospective analysis
  di: Atsushi Takeno, et al.
  Pubblicazione: (2024)
• Impact of Neoadjuvant Docetaxel, Cisplatin, and 5‐Fluorouracil Therapy on Synchronous Early‐Stage Oropharyngeal/Hypopharyngeal Cancer in Patients With Esophageal Cancer
  di: Tatsuya Ito, et al.
  Pubblicazione: (2026)